There’s a new sense of excitement surrounding GlycoMimetics Inc. (GLYC)

The closing price of GlycoMimetics Inc. (NASDAQ: GLYC) was $3.17 for the day, up 10.45% from the previous closing price of $2.87. In other words, the price has increased by $+0.3000 from its previous closing price. On the day, 925533 shares were traded. GLYC stock price reached its highest trading level at $3.2181 during the session, while it also had its lowest trading level at $2.8650.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.



Our analysis of GLYC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.90 and its Current Ratio is at 6.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on November 12, 2021, Upgraded its rating to Buy and sets its target price to $4 from $3 previously.

On November 14, 2019, ROTH Capital started tracking the stock assigning a Buy rating and target price of $12.

SunTrust Downgraded its Buy to Hold on August 05, 2019, whereas the target price for the stock was revised from $23 to $5.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 05 when SANDELL SCOTT D sold 71,362 shares for $2.76 per share. The transaction valued at 196,859 led to the insider holds 3,881,933 shares of the business.

SANDELL SCOTT D sold 101,984 shares of GLYC for $296,743 on Jan 04. The 10% Owner now owns 3,914,072 shares after completing the transaction at $2.91 per share. On Jan 03, another insider, SANDELL SCOTT D, who serves as the 10% Owner of the company, sold 174,814 shares for $2.99 each. As a result, the insider received 522,711 and left with 3,960,002 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 1787.52 while its Price-to-Book (P/B) ratio in mrq is 3.45.

Stock Price History:

Over the past 52 weeks, GLYC has reached a high of $3.30, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is 2.2934, while the 200-Day Moving Average is calculated to be 1.1030.

Shares Statistics:

GLYC traded an average of 659.43K shares per day over the past three months and 572.73k shares per day over the past ten days. A total of 52.42M shares are outstanding, with a floating share count of 51.08M. Insiders hold about 1.50% of the company’s shares, while institutions hold 53.40% stake in the company. Shares short for GLYC as of Oct 13, 2022 were 479.74k with a Short Ratio of 0.61M, compared to 497.31k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.92% and a Short% of Float of 1.46%.

Earnings Estimates

The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.26 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.3, while EPS last year was -$0.34. The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.21 and low estimates of -$0.31.

Analysts are recommending an EPS of between -$0.95 and -$1.14 for the fiscal current year, implying an average EPS of -$1.05. EPS for the following year is -$0.82, with 3 analysts recommending between -$0.5 and -$1.11.

Revenue Estimates

A total of 2 analysts have provided revenue estimates for GLYC’s current fiscal year. The highest revenue estimate was $70k, while the lowest revenue estimate was $70k, resulting in an average revenue estimate of $70k. In the same quarter a year ago, actual revenue was $1.16M, down -94.00% from the average estimate.